ENGN.NASDAQEngene Holdings INC

Form 4: enGene Holdings Inc. Director Exercises Stock Options

Sentiment:

SEC Form 4 Filing

📋All filings for Engene Holdings INC
🔒Login to Follow

Richard M. Glickman, a director of enGene Holdings Inc., exercised stock options to acquire 120 common shares at a price of $0.89 on May 28, 2024.

Summary

  • On May 28, 2024, Richard M. Glickman, a director of enGene Holdings Inc., exercised stock options to acquire 120 common shares.
  • The transaction was executed at a price of $0.89 per share.
  • Following the transaction, Glickman directly owns 24,675 common shares.
  • The stock options were fully vested and exercisable.
  • The options were originally set to expire on December 4, 2023, but the expiration date was extended to June 26, 2024, following the filing of enGene Holdings Inc.'s Form S-8 on February 27, 2024.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction, which is neutral in sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their holdings in the company's stock.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it involves a small number of shares.

Key Dates

DateDescription
February 27, 2024enGene Holdings Inc. filed Form S-8, which led to the extension of the option expiry date.
May 28, 2024Richard M. Glickman exercised stock options to acquire 120 common shares.
May 29, 2024Date of signature for the Form 4 filing.
June 26, 2024Extended expiration date for the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.